Devices to lead heart disease fight

any previous ACC meeting. And the one that was featured -- with a new blood clot preventer from Bayer AG and Johnson & Johnson called Xarelto -- proved a failure in the population in which it was tested. Evidence of the rise of devices was everywhere....